aod9604 fda approval status AOD-9604 Before and After: Results AOD9604 - Oath Research
Description
The most commonly reported adverse effects are the GI symptoms associated with tirzepatide (nausea, reduced appetite) plus the mild headache occasionally seen with AOD 9604
It is a small synthetic molecule that blocks an enzyme called NNMT (nicotinamide N-methyltransferase)
Other possible symptoms may include headache or tiredness
Chronic stress and alcohol abuse may also indirectly affect B12 levels
Obesity market overview
